• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用遗传变异的氨基酸水平信噪比分析确定变异致病性的可能性

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation.

作者信息

Jones Edward G, Landstrom Andrew P

机构信息

Department of Pediatrics, Baylor College of Medicine.

Department of Pediatrics, Division of Cardiology, Duke University School of Medicine;

出版信息

J Vis Exp. 2019 Jan 16(143). doi: 10.3791/58907.

DOI:10.3791/58907
PMID:30735170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6698361/
Abstract

Advancements in the cost and speed of next generation genetic sequencing have generated an explosion of clinical whole exome and whole genome testing. While this has led to increased identification of likely pathogenic mutations associated with genetic syndromes, it has also dramatically increased the number of incidentally found genetic variants of unknown significance (VUS). Determining the clinical significance of these variants is a major challenge for both scientists and clinicians. An approach to assist in determining the likelihood of pathogenicity is signal-to-noise analysis at the protein sequence level. This protocol describes a method for amino acid-level signal-to-noise analysis that leverages variant frequency at each amino acid position of the protein with known protein topology to identify areas of the primary sequence with elevated likelihood of pathologic variation (relative to population "background" variation). This method can identify amino acid residue location "hotspots" of high pathologic signal, which can be used to refine the diagnostic weight of VUSs such as those identified by next generation genetic testing.

摘要

新一代基因测序在成本和速度方面的进步引发了临床全外显子组和全基因组检测的激增。虽然这使得与遗传综合征相关的可能致病突变的识别有所增加,但也显著增加了偶然发现的意义未明的基因变异(VUS)的数量。确定这些变异的临床意义对科学家和临床医生来说都是一项重大挑战。一种有助于确定致病性可能性的方法是在蛋白质序列水平进行信号噪声分析。本方案描述了一种氨基酸水平信号噪声分析方法,该方法利用已知蛋白质拓扑结构的蛋白质每个氨基酸位置的变异频率,来识别一级序列中病理变异可能性升高的区域(相对于群体“背景”变异)。这种方法可以识别高病理信号的氨基酸残基位置“热点”,可用于完善VUS的诊断权重,如下一代基因检测所识别的那些VUS。

相似文献

1
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation.利用遗传变异的氨基酸水平信噪比分析确定变异致病性的可能性
J Vis Exp. 2019 Jan 16(143). doi: 10.3791/58907.
2
: A Web-Based Precision Medicine Tool for Predicting Variant Pathogenicity in Cardiomyopathy- and Channelopathy-Associated Genes.: 一个基于网络的精准医学工具,用于预测心肌病和通道病相关基因变异的致病性。
Circ Genom Precis Med. 2023 Aug;16(4):317-327. doi: 10.1161/CIRCGEN.122.003911. Epub 2023 Jul 6.
3
A likelihood-based approach to assessing frequency of pathogenicity among variants of unknown significance in susceptibility genes.一种基于似然性的方法,用于评估易感基因中意义未明变异的致病性频率。
Stat Med. 2021 Feb 10;40(3):593-606. doi: 10.1002/sim.8791. Epub 2020 Oct 29.
4
Identification of Genetic Alterations, as Causative Genetic Defects in Long QT Syndrome, Using Next Generation Sequencing Technology.使用下一代测序技术鉴定作为长QT综合征致病基因缺陷的基因改变
PLoS One. 2014 Dec 10;9(12):e114894. doi: 10.1371/journal.pone.0114894. eCollection 2014.
5
Whole-Exome Molecular Autopsy After Exertion-Related Sudden Unexplained Death in the Young.年轻人群中运动相关不明原因猝死的全外显子分子尸检
Circ Cardiovasc Genet. 2016 Jun;9(3):259-65. doi: 10.1161/CIRCGENETICS.115.001370. Epub 2016 Apr 25.
6
Re-evaluating pathogenicity of variants associated with the long QT syndrome.重新评估与长 QT 综合征相关的变异体的致病性。
J Cardiovasc Electrophysiol. 2018 Jan;29(1):98-104. doi: 10.1111/jce.13355. Epub 2017 Nov 1.
7
PaPI: pseudo amino acid composition to score human protein-coding variants.PaPI:用于评估人类蛋白质编码变体的伪氨基酸组成。
BMC Bioinformatics. 2015 Apr 19;16:123. doi: 10.1186/s12859-015-0554-8.
8
Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes.扩展家系中家系似然性分析对癌症风险基因中意义不确定的罕见变异进行分类的能力。
Fam Cancer. 2017 Oct;16(4):611-620. doi: 10.1007/s10689-017-9989-6.
9
Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.针对导致心肌病的突变进行的46基因和临床外显子组测序。
Mol Cell Probes. 2015 Oct;29(5):308-14. doi: 10.1016/j.mcp.2015.05.004. Epub 2015 May 12.
10
and Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants.对一小部分意大利乳腺癌/卵巢癌患者进行下一代测序检测:新的致病性和未知临床意义的变异体。
Int J Mol Sci. 2019 Jul 12;20(14):3442. doi: 10.3390/ijms20143442.

引用本文的文献

1
: A Web-Based Precision Medicine Tool for Predicting Variant Pathogenicity in Cardiomyopathy- and Channelopathy-Associated Genes.: 一个基于网络的精准医学工具,用于预测心肌病和通道病相关基因变异的致病性。
Circ Genom Precis Med. 2023 Aug;16(4):317-327. doi: 10.1161/CIRCGEN.122.003911. Epub 2023 Jul 6.
2
Determining the Likelihood of Disease Pathogenicity Among Incidentally Identified Genetic Variants in Rare Dilated Cardiomyopathy-Associated Genes.确定偶然发现的罕见扩张型心肌病相关基因中的遗传变异的疾病致病性的可能性。
J Am Heart Assoc. 2022 Oct 4;11(19):e025257. doi: 10.1161/JAHA.122.025257. Epub 2022 Sep 21.
3
From diagnostic testing to precision medicine: the evolving role of genomics in cardiac channelopathies and cardiomyopathies in children.从诊断检测到精准医学:基因组学在儿童心脏通道病和心肌病中的作用演变。
Curr Opin Genet Dev. 2022 Oct;76:101978. doi: 10.1016/j.gde.2022.101978. Epub 2022 Sep 1.
4
GENESIS: Gene-Specific Machine Learning Models for Variants of Uncertain Significance Found in Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome-Associated Genes.GENESIS:儿茶酚胺能多形性室性心动过速和长 QT 综合征相关基因中不确定意义变异的基因特异性机器学习模型。
Circ Arrhythm Electrophysiol. 2022 Apr;15(4):e010326. doi: 10.1161/CIRCEP.121.010326. Epub 2022 Mar 31.
5
Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.肌钙蛋白基因中心肌病相关变异的荟萃分析确定了与更差临床结局相关的基因座和基因内热点。
J Mol Cell Cardiol. 2020 May;142:118-125. doi: 10.1016/j.yjmcc.2020.04.005. Epub 2020 Apr 9.
6
Protein Subdomain Enrichment of Variants Identify a Novel Predicted Pathogenic Hotspot.蛋白质亚结构域变异富集鉴定出一个新的预测致病热点。
Front Cardiovasc Med. 2020 Feb 7;7:8. doi: 10.3389/fcvm.2020.00008. eCollection 2020.

本文引用的文献

1
Predicting the clinical impact of human mutation with deep neural networks.利用深度神经网络预测人类突变的临床影响。
Nat Genet. 2018 Aug;50(8):1161-1170. doi: 10.1038/s41588-018-0167-z. Epub 2018 Jul 23.
2
Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.全基因组测序可改善肥厚型心肌病患者基因检测的结果。
J Am Coll Cardiol. 2018 Jul 24;72(4):419-429. doi: 10.1016/j.jacc.2018.04.078.
3
Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise.在儿科全外显子组测序中对与长 QT 综合征相关基因中偶然发现的变异进行氨基酸水平的信号噪声分析反映了背景遗传噪声。
Heart Rhythm. 2018 Jul;15(7):1042-1050. doi: 10.1016/j.hrthm.2018.02.031. Epub 2018 Mar 2.
4
Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic Testing.长 QT 综合征基因检测中潜在致心律失常性常见遗传变异的分类和报告。
Circulation. 2018 Feb 6;137(6):619-630. doi: 10.1161/CIRCULATIONAHA.117.030142.
5
A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.肥厚型心肌病患者全基因组测序与多基因检测面板的比较
Circ Cardiovasc Genet. 2017 Oct;10(5). doi: 10.1161/CIRCGENETICS.117.001768.
6
Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.在重症监护病房对婴儿使用外显子组测序:严重单基因疾病的确诊及对医疗管理的影响
JAMA Pediatr. 2017 Dec 4;171(12):e173438. doi: 10.1001/jamapediatrics.2017.3438.
7
Artificial Intelligence in Precision Cardiovascular Medicine.人工智能在精准心血管医学中的应用。
J Am Coll Cardiol. 2017 May 30;69(21):2657-2664. doi: 10.1016/j.jacc.2017.03.571.
8
Using high-resolution variant frequencies to empower clinical genome interpretation.利用高分辨率变异频率增强临床基因组解读。
Genet Med. 2017 Oct;19(10):1151-1158. doi: 10.1038/gim.2017.26. Epub 2017 May 18.
9
Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.在大量临床全外显子基因检测转诊队列中解读与儿茶酚胺能多形性室性心动过速相关基因的偶然发现变异体。
Circ Arrhythm Electrophysiol. 2017 Apr;10(4). doi: 10.1161/CIRCEP.116.004742.
10
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议,2016年更新版(美国医学遗传学与基因组学学会次要发现v2.0):美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.